Related references
Note: Only part of the references are listed.Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES)
Adeel A. Butt et al.
CLINICAL INFECTIOUS DISEASES (2020)
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
Chun-Jen Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
Darrick K. Li et al.
HEPATOLOGY (2018)
Epidemiology and clinical outcomes of hepatitis delta (D) virus infection in Queensland, Australia
Sarah Coghill et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES
J. Y. Chen et al.
JOURNAL OF VIRAL HEPATITIS (2018)
HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES
Adeel A. Butt et al.
LIVER INTERNATIONAL (2018)
Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES
A. A. Butt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons
K. W. Chew et al.
JOURNAL OF VIRAL HEPATITIS (2017)
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences
S. Pol et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES
Adeel Ajwad Butt et al.
CLINICAL INFECTIOUS DISEASES (2017)
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
Vincent Lo Re et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Share Paper
